[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@MedUpdateOn1ine](/creator/twitter/MedUpdateOn1ine)
"Alexion to present long-term Ultomiris and Soliris data in NMOSD at ECTRIMS 2025"  
[X Link](https://x.com/MedUpdateOn1ine/status/1969235124463001830) [@MedUpdateOn1ine](/creator/x/MedUpdateOn1ine) 2025-09-20T03:00Z 6223 followers, XX engagements


"Groundbreaking study published in JAMA Neurology demonstrates effectiveness of BrainSense Adaptive deep brain stimulation for people with Parkinsons - Medtronic"  
[X Link](https://x.com/MedUpdateOn1ine/status/1977902248635040157) [@MedUpdateOn1ine](/creator/x/MedUpdateOn1ine) 2025-10-14T01:00Z 6226 followers, XX engagements


"Inspire V Data published at ISSS/AAO-HNS Meetings - Inspire Medical Systems"  
[X Link](https://x.com/MedUpdateOn1ine/status/1978627010789269760) [@MedUpdateOn1ine](/creator/x/MedUpdateOn1ine) 2025-10-16T01:00Z 6221 followers, XX engagements


"FDA approves updated indication statement for Rinvoq (upadacitinib) for the treatment of inflammatory bowel disease - AbbVie"  
[X Link](https://x.com/MedUpdateOn1ine/status/1980076562482409495) [@MedUpdateOn1ine](/creator/x/MedUpdateOn1ine) 2025-10-20T01:00Z 6223 followers, XX engagements


"Gilead Sciences to present new antiviral research across HIV hepatitis and respiratory viruses at IDWeek 2025"  
[X Link](https://x.com/MedUpdateOn1ine/status/1980215913560277000) [@MedUpdateOn1ine](/creator/x/MedUpdateOn1ine) 2025-10-20T10:13Z 6225 followers, XXX engagements


"Fabhalta (iptacopan) meets Phase III primary endpoint slows kidney function decline in patients with IgA nephropathy - Novartis"  
[X Link](https://x.com/MedUpdateOn1ine/status/1980801339060854910) [@MedUpdateOn1ine](/creator/x/MedUpdateOn1ine) 2025-10-22T01:00Z 6220 followers, XX engagements


"PSMAddition data show Pluvicto delays progression to end-stage prostate cancer - Novartis"  
[X Link](https://x.com/MedUpdateOn1ine/status/1981163724334375321) [@MedUpdateOn1ine](/creator/x/MedUpdateOn1ine) 2025-10-23T01:00Z 6223 followers, XX engagements


"Verzenio (abemaciclib) prolonged survival in HR+ HER2- high-risk early breast cancer with two years of treatment - Eli Lilly"  
[X Link](https://x.com/MedUpdateOn1ine/status/1981888494738747846) [@MedUpdateOn1ine](/creator/x/MedUpdateOn1ine) 2025-10-25T01:00Z 6221 followers, XX engagements